Welcome to our dedicated page for Braemar Hotels & Resorts SEC filings (Ticker: BHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Braemar Hotels & Resorts Inc. filings document the regulatory record of a Maryland REIT that owns luxury hotel and resort assets and reports as a public company with NYSE-listed common stock and listed Series B and Series D preferred stock. Its Form 8-K filings include operating and financial results, hotel performance metrics, Regulation FD dividend releases, material agreements, and other event disclosures.
The filing record also covers the externally advised structure involving Braemar Hospitality Limited Partnership, Braemar TRS Corporation, Ashford Inc., and Ashford Hospitality Advisors LLC. Disclosures address the advisory agreement, preferred-stock dividend treatment across Series B, Series D, Series E, and Series M securities, liquidation-value reporting for non-traded redeemable preferred stock, governance matters, officer-transition reporting, exhibits, and Inline XBRL cover-page data.
Braemar Hotels & Resorts Inc. faces a proxy solicitation by Al Shams Investments Limited and Wafic Rida Said, who filed Amendment No. 11 to a Schedule 13D on June 29, 2026. The participants say they will furnish a definitive Schedule 14A and a WHITE Universal Proxy Card to solicit shareholder proxies for the Annual Meeting.
Braemar Hotels & Resorts Inc. has extended its $43.4 million mortgage loan secured by the 170-room Ritz-Carlton Lake Tahoe. The loan’s initial maturity date of July 15, 2026 has been pushed to October 15, 2026, giving the company additional time before repayment is due.
The extended loan is priced at SOFR + 325 basis points, and Braemar also has a further three-month extension option on the same terms at its discretion. Management notes this loan represents the company’s only remaining 2026 debt maturity and indicates that, once it refinances this loan later in the year, it expects to have no other final maturities until 2028.
Braemar Hotels & Resorts Inc. announced that its Board declared June 2026 cash dividends on all of its outstanding preferred stock series. The Series B Cumulative Convertible Preferred dividend is $0.1146 per diluted share and the Series D Cumulative Preferred dividend is $0.17186 per diluted share, both payable on July 15, 2026 to holders of record on June 30, 2026. The Series E Redeemable Preferred dividend is $0.15625 per share, and the Series M Redeemable Preferred dividends are $0.17917 or $0.17708 per share depending on CUSIP, with the same record and payment dates.
Al Shams Investments Limited and Wafic Rida Said are soliciting proxies for Braemar Hotels & Resorts Inc. The participants say they will file a definitive Schedule 14A and furnish a WHITE Universal Proxy Card for the company’s Annual Meeting. The filing notes a press release and an Amendment No. 10 to Schedule 13D, both dated June 15, 2026.
The materials will be available free on the SEC website and will describe the participants’ direct or indirect interests and the matters they intend to present at the Annual Meeting.
Braemar Hotels & Resorts Inc. is overhauling its structure after completing a strategic review, planning to become a self-managed REIT, remain publicly traded, and terminate its advisory relationship with Ashford Inc. and affiliates. Management, including CEO Richard Stockton, will be employed directly by Braemar.
The company intends to focus on a streamlined portfolio of approximately six to eight luxury properties in the U.S. and Caribbean, which had a gross asset value of over $1 billion and generated total annual revenue of $300 to $350 million for the trailing twelve months ending March 31, 2026. Braemar expects the new in-house model to reduce general and administrative costs by more than $25 million annually.
The Board plans a near-total refresh, adding five new independent directors and an independent Chair while all current directors except Mr. Stockton step down, with no new directors having relationships with Ashford or its leadership. Braemar also expects to sell an additional two or three assets to fund obligations tied to the termination of the Ashford advisory relationship, including a Company Sale Fee and Master Agreement Termination Fee, while retaining a focused luxury portfolio.
Braemar Hotels & Resorts Inc. has entered into a material definitive Agreement of Purchase and Sale through its indirect subsidiaries to sell three luxury hotel properties for a total cash purchase price of $437.5 million, subject to customary prorations and adjustments.
The properties are The Ritz-Carlton Sarasota in Florida, and Hotel Yountville and Bardessono Hotel and Spa in Yountville, California. The transaction is expected to close in approximately 20–35 days, subject to customary closing conditions, and the parties note there can be no assurance the sale will be completed on these terms or at all.
Al Shams Investments Limited and Wafic Rida Said are soliciting proxies for Braemar Hotels & Resorts Inc.'s annual meeting and intend to file a Definitive Proxy Statement on Schedule 14A and a WHITE Universal Proxy Card to solicit shareholder votes. The Participants filed Amendment No. 9 to their Schedule 13D on June 10, 2026.
Braemar Hotels & Resorts Inc. shareholder Al Shams Investments Ltd and related reporting person Wafic Rida Said report beneficial ownership of 6,513,000 shares of common stock, representing 9.55% of the class. They hold shared voting and dispositive power over these shares, with no sole power reported.
The filing amends the stated purpose of their investment to reflect an activist stance. On June 10, 2026, they issued a press release with an open letter to the outside directors, urging them to resist what they describe as efforts by Ashford executives to manipulate the director nomination and election process. They state that the current board has, in their view, no legitimacy and that shareholders should be able to elect new directors at the 2026 Annual Meeting.
The investors reiterate that ASIL intends to nominate several director candidates at the 2026 Annual Meeting and is preparing its nomination notice. They criticize changes to the director nominee Questionnaire under the issuer’s Fifth Amended and Restated Bylaws, noting it is longer by seven pages and more than 60 additional questions and sub-questions compared with the form used for the 2025 Annual Meeting. They believe these revisions impede shareholder rights and create procedural obstacles for shareholder-nominated candidates. The open letter and related press release are filed as exhibits.